Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in PGEN — Precigen, Inc.

CIK 861177 NEW YORK, NY
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,900,070
+$527,929 QoQ
Shares Held
333,346
-6.0% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 210 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 41% Shared 0% None 59%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. PGEN ranks #103 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,086,683 $1,533,248,041
2 REGN
Regeneron Pharmaceuticals, Inc.
 716,560 $446,803,817
3 ALNY
Alnylam Pharmaceuticals, Inc.
 727,848 $219,104,078
4 INCY
Incyte Corp
 1,508,720 $171,028,494
5 RVMD
Revolution Medicines, Inc.
 912,335 $170,862,094
6 INSM
INSMED Inc
 1,335,071 $142,345,265
7 IONS
Ionis Pharmaceuticals Inc
 1,454,672 $115,340,938
8 MRNA
Moderna, Inc.
 1,521,849 $106,575,080

All Filings in PGEN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,900,070 333,346
2026-03-31 $1,372,141 354,559
2025-12-31 $977,479 233,847
2023-06-30 $123,132 107,073
2023-03-31 $113,496 107,073
2022-12-31 $201,980 132,883
2022-09-30 $281,711 132,883
2022-06-30 $229,188 171,038
2022-03-31 $206,462 97,850
2021-12-31 $363,022 97,850
2021-09-30 $488,268 97,850
2021-06-30 $637,980 97,850
2021-03-31 $618,933 89,831
2020-12-31 $783,675 76,831
2020-09-30 $308,108 88,031
2020-06-30 $439,272 88,031
2020-03-31 $324,101 95,324